Regional Anesthesia in Colon Rectal Surgery

NCT ID: NCT00684229

Last Updated: 2016-09-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2007-12-31

Study Completion Date

2013-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will compare recurrence rates in patients with colorectal cancer who will be randomly assigned to epidural anesthesia/analgesia combined with general anesthesia or to general anesthesia followed by opioid analgesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study population will consist of patients who are scheduled for open laparoscopic or laparoscopic assisted surgery for colon cancer. Patients will randomized into one of two groups. The intervention group will receive combined regional and general anesthesia during surgery. Postoperative pain treatment will be based on regional anesthesia techniques. The Control group will receive general anesthesia during surgery. Postoperative pain treatment will be based primarily on opioids. After surgery, patients will be followed daily during their hospital stay. Patients will be contacted by telephone every 6 months for five years. Quality of life questionnaires will be administered at these follow ups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colon Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Regional anesthesia and analgesia

Regional anesthesia and analgesia (either epidural or paravertebral anesthesia).

Group Type ACTIVE_COMPARATOR

Regional anesthesia and analgesia

Intervention Type PROCEDURE

Post-operative analgesia will be epidural bupivacaine and fentanyl as well as intravenous morphine.

general anesthesia followed by opioid analgesia

Subjects randomized to arm 2 will receive general anesthesia followed by opioid analgesia.

Group Type ACTIVE_COMPARATOR

general anesthesia followed by opioid analgesia

Intervention Type DRUG

sevoflurane general anesthesia and postoperative opioid analgesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Regional anesthesia and analgesia

Post-operative analgesia will be epidural bupivacaine and fentanyl as well as intravenous morphine.

Intervention Type PROCEDURE

general anesthesia followed by opioid analgesia

sevoflurane general anesthesia and postoperative opioid analgesia

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary colon cancer without known extension beyond colon (T3, N0, M0)
* Scheduled for open, laparoscopic assisted and laparoscopic resection of the colon.
* Written informed consent, including willingness to be randomized to epidural anesthesia/analgesia or to sevoflurane general anesthesia and postoperative opioid analgesia.

Exclusion Criteria

* Previous surgery for colon cancer;
* Any contraindication to epidural anesthesia or analgesia (including coagulopathy, abnormal anatomy);
* Any contraindication to midazolam, propofol, sevoflurane, fentanyl, or morphine;
* Age \<18 or \>85 years old;
* ASA Physical Status ≥4;
* Other cancer not believed by the attending surgeon to be in long-term remission;
* Systemic disease believed by the attending surgeon or anesthesiologist to present ≥25% two-year mortality.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Cleveland Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Andrea Kurz

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Daniel I Sessler, MD

Role: STUDY_CHAIR

The Cleveland Clinic

Andrea Kurz, MD

Role: PRINCIPAL_INVESTIGATOR

The Cleveland Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cleveland Clinic

Cleveland, Ohio, United States

Site Status

Hospital Italiano de Buenos Aires

Buenos Aires, , Argentina

Site Status

University of Dusseldorf

Düsseldorf, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

07-933

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.